Hepatocellular Carcinoma, Alpha Fetoprotein, and Liver Allocation for Transplantation: Past, Present and Future
- PMID: 36290870
- PMCID: PMC9600271
- DOI: 10.3390/curroncol29100593
Hepatocellular Carcinoma, Alpha Fetoprotein, and Liver Allocation for Transplantation: Past, Present and Future
Abstract
Hepatocellular carcinoma (HCC) is one of the leading indications for liver transplantation and has been the treatment of choice due to the oncologic benefit for patients with advanced chronic liver disease (AdvCLD) and small tumors for the last 25 years. For HCC patients undergoing liver transplantation, alpha fetoprotein (AFP) has increasingly been applied as an independent predictor for overall survival, disease free recurrence, and waitlist drop out. In addition to static AFP, newer studies evaluating the AFP dynamic response to downstaging therapy show enhanced prognostication compared to static AFP alone. While AFP has been utilized to select HCC patients for transplant, despite years of allocation policy changes, the US allocation system continues to take a uniform approach to HCC patients, without discriminating between those with favorable or unfavorable tumor biology. We aim to review the history of liver allocation for HCC in the US, the utility of AFP in liver transplantation, the implications of weaving AFP as a biomarker into policy. Based on this review, we encourage the US transplant community to revisit its HCC organ allocation model, to incorporate more precise oncologic principles for patient selection, and to adopt AFP dynamics to better stratify waitlist dropout risk.
Keywords: alpha fetoprotein; hepatocellular carcinoma; liver allocation; liver transplantation.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
Similar articles
-
Homocysteine: A novel prognostic biomarker in liver transplantation for alpha-fetoprotein- negative hepatocellular carcinoma.Cancer Biomark. 2020;29(2):197-206. doi: 10.3233/CBM-201545. Cancer Biomark. 2020. PMID: 32623388
-
Pre-transplant alpha-fetoprotein is associated with post-transplant hepatocellular carcinoma recurrence mortality.Clin Transplant. 2019 Jul;33(7):e13634. doi: 10.1111/ctr.13634. Epub 2019 Jun 25. Clin Transplant. 2019. PMID: 31177570 Free PMC article.
-
Dynamic α-Fetoprotein Response and Outcomes After Liver Transplant for Hepatocellular Carcinoma.JAMA Surg. 2021 Jun 1;156(6):559-567. doi: 10.1001/jamasurg.2021.0954. JAMA Surg. 2021. PMID: 33950167 Free PMC article.
-
The Importance of AFP in Liver Transplantation for HCC.J Gastrointest Cancer. 2020 Dec;51(4):1127-1132. doi: 10.1007/s12029-020-00486-w. J Gastrointest Cancer. 2020. PMID: 32845425 Review.
-
Patient Selection for Downstaging of Hepatocellular Carcinoma Prior to Liver Transplantation-Adjusting the Odds?Transpl Int. 2022 Apr 21;35:10333. doi: 10.3389/ti.2022.10333. eCollection 2022. Transpl Int. 2022. PMID: 35529597 Free PMC article. Review.
Cited by
-
Cathelicidin Antimicrobial Peptide Acts as a Tumor Suppressor in Hepatocellular Carcinoma.Int J Mol Sci. 2023 Oct 27;24(21):15652. doi: 10.3390/ijms242115652. Int J Mol Sci. 2023. PMID: 37958632 Free PMC article.
-
Circadian Rhythm Disruption in Hepatocellular Carcinoma Investigated by Integrated Analysis of Bulk and Single-Cell RNA Sequencing Data.Int J Mol Sci. 2024 May 25;25(11):5748. doi: 10.3390/ijms25115748. Int J Mol Sci. 2024. PMID: 38891936 Free PMC article.
-
Development of a deep learning model for predicting recurrence of hepatocellular carcinoma after liver transplantation.Front Med (Lausanne). 2024 Jun 11;11:1373005. doi: 10.3389/fmed.2024.1373005. eCollection 2024. Front Med (Lausanne). 2024. PMID: 38919938 Free PMC article.
-
Impact of Pre-Liver Transplant Treatments on the Imaging Accuracy of HCC Staging and Their Influence on Outcomes.Cancers (Basel). 2024 Mar 4;16(5):1043. doi: 10.3390/cancers16051043. Cancers (Basel). 2024. PMID: 38473400 Free PMC article.
-
Laparoscopic-assisted microwave ablation in treatment of small hepatocellular carcinoma: safety and efficacy in comparison with laparoscopic hepatectomy.BMC Surg. 2024 May 7;24(1):138. doi: 10.1186/s12893-024-02432-0. BMC Surg. 2024. PMID: 38715071 Free PMC article.
References
-
- OPTN 2020 Annual Report of the U.S. Organ Procurement and Transplantation Network and the Scientific Registry of Transplant Recipients: Transplant Data 2009–2020. [(accessed on 8 January 2022)]. Available online: https://onlinelibrary.wiley.com/doi/full/10.1111/ajt.16975. - DOI
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous